Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
Reports from the United States advance knowledge in cancer treatment research
May 18th, 2006
Reports from the United States highlight recent research in cancer treatment. Study 1: Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. According to a study from the United States, "We searched for cell-surface-associated proteins overexpressed on B cell chronic lymphocytic leukemia (CLL) to use as therapeutic antibody targets. Antibodies binding the immunosuppressive molecule CD200 were identified by cell panning of an antibody phage display library derived from rabbits immunized with primary CLL cells. B cells from 87 CLL patients exhibited 1.6- to 5.4-fold cell-surface up-regulation...
Source: Biotech Business Week (2006-05-18)
|
